Tradestie Institutional Equity Comparison Engine
MYO vs MBOT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MYO Overall Edge
MYO Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Myomo Inc. (MYO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MBOT counters with relative strength in Valuation. Fundamentally, MYO trades at N/M Forward P/E with -21.8% operating margin (+22.2% YoY revenue) versus MBOT at 31.8x Forward P/E and -5057.2% operating margin (+0.0% YoY). In options structure, MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro) against MBOT sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MBOT
MYO N/M vs MBOT 31.8x Fwd P/E
Growth & Margin Winner
MYO
Op Margin -21.8% vs -5057.2% ยท YoY +22.2% vs +0.0%
Momentum & Technical Winner
MYO
1Y +12.3% vs -64.6% ยท 52W Pos 16% vs 7%
Options & Structure Winner
MYO
UNCLASSIFIED (81st %ile IV) vs BREAKDOWN (30th %ile IV)
MYO
NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap
$33.7M
1M Return
-33.52%
1Y Return
+12.3%
Forward P/E
N/M
Unified AI Score
40.1 / 100
SELL
Tech 25.0
Fund 43.0
Flow 58.0
Mom 59.0
MBOT
NASDAQ
Microbot Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.68
-8.52% 1D
Market Cap
$49.9M
1M Return
-27.81%
1Y Return
-64.58%
Forward P/E
31.8x
Unified AI Score
54.9 / 100
HOLD
Tech 48.0
Fund 55.0
Flow 68.0
Mom 49.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MYO +12.3%
MBOT -64.58%
Spread: +76.88 pp (MYO Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MYO Revenue | MBOT Revenue | MYO Op. Margin | MBOT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -430.8% | N/A | MYO |
| FY2019 | $0M | N/A | -281.3% | N/A | MYO |
| FY2020 | $10M | N/A | -138.5% | N/A | MYO |
| FY2021 | $10M | N/A | -74.1% | N/A | MYO |
| FY2022 | $20M | N/A | -68.6% | N/A | MYO |
| FY2023 | $20M | N/A | -42.8% | N/A | MYO |
| FY2024 | $30M | N/A | -19.1% | N/A | MYO |
| FY2025 | $40M | N/A | -35.2% | N/A | MYO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MYO | MBOT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $33.7M | $49.9M | Larger Scale | MBOT |
| Trailing P/E Ratio Valuation | N/M | 31.8x | Lower Multiple | MBOT |
| Forward P/E Ratio Valuation | N/M | 31.8x | Lower Multiple | MBOT |
| Revenue Growth (YoY) Growth | +22.2% | +0.0% | Higher Growth | MYO |
| Operating Margin (TTM) Profitability | -21.8% | -5057.2% | Higher Margin | MYO |
| Net Profit Margin Profitability | -33.1% | 0.0% | Higher Margin | MBOT |
| Return on Equity (ROE) Capital Efficiency | -173.5% | -26.3% | Higher ROE | MBOT |
| 52-Week Range Position Momentum | 16% ($1โ$2) | 7% ($1โ$3) | Stronger Trend | MYO |
| Beta / 30D Volatility Risk Regime | 2.22ฮฒ ยท 107% Vol | 1.68ฮฒ ยท 145% Vol | Lower Realized Risk | MYO |
| Unified Institutional Score Composite Signal | 40.1 / 100 (SELL) | 54.9 / 100 (HOLD) | Higher Composite | MBOT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MYO vs MBOT Buy Guide
MYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
81st %ile
IV Regime
Extreme (>80th %ile)
MBOT
BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
30th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MYO nor MBOT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.